Rifabutin [clinicaltrials_resource:79a4745cac85ba5674a29f920822f23a]
Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole-Trimethoprim and Dapsone and Their Hydroxylamine Metabolites [clinicaltrials:NCT00000826]Study of How Indinavir (an Anti-HIV Drug) and Rifabutin (a Drug Used to Treat MAC, an HIV-Associated Disease) Interact in HIV-Positive and HIV-Negative Adults [clinicaltrials:NCT00000877]The Safety and Effectiveness of Rifabutin, Combined With Clarithromycin or Azithromycin, in HIV-Infected Patients [clinicaltrials:NCT00001023]The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected Patients [clinicaltrials:NCT00001030]Study of Four Different Treatment Approaches for Patients Who Have Mycobacterium Avium Complex Disease (MAC) Plus AIDS [clinicaltrials:NCT00001047]A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDS [clinicaltrials:NCT00001058]A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-Avium Complex (MAC) Bacteremia in Patients With AIDS [clinicaltrials:NCT00001995]Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial [clinicaltrials:NCT00002032]Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in HIV Positive Patients With CD4 Counts = or < 200: Treatment IND Study [clinicaltrials:NCT00002080]A Three-Arm Comparative Trial for the Treatment of MAC Bacteremia in AIDS: A Clarithromycin/Ethambutol Regimen Containing Rifabutin (450 Mg) or Rifabutin (300 Mg) or Placebo [clinicaltrials:NCT00002101]A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected Patients [clinicaltrials:NCT00002122]Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial [clinicaltrials:NCT00002267]A Study of Rifabutin, Used Alone or With Ethambutol in the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in Patients With AIDS [clinicaltrials:NCT00002343]Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis [clinicaltrials:NCT00004736]TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TB [clinicaltrials:NCT00023348]TBTC Study 23: Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen [clinicaltrials:NCT00023361]TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB [clinicaltrials:NCT00023400]TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz [clinicaltrials:NCT00023413]
intervention [clinicaltrials_vocabulary:intervention]
Rifabutin [clinicaltrials_resource:79a4745cac85ba5674a29f920822f23a]
Bio2RDF identifier
79a4745cac85ba5674a29f920822f23a
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:79a4745cac85ba5674a29f920822f23a
intervention name [clinicaltrials_vocabulary:intervention-name]
identifier
clinicaltrials_resource:79a4745cac85ba5674a29f920822f23a
title
Rifabutin
@en
type
label
Rifabutin [clinicaltrials_resource:79a4745cac85ba5674a29f920822f23a]
@en